← Insider buys
CVS

CVS Health Corporation · Healthcare

EVP, Chief Exp & Tech Officer Tilak Mandadi sold $6.2M of CVS Health Corporation

Sold$6,230,379
$89.58Price
69,551Shares
−87%Stake

What CVS did after the filing

Filed May 11Copier in May 12
The stock from Tue, May 12 open, $92.22
+13.5%
S&P 500, same days
−0.4%

Measured over 30 trading days, to the Jun 25 close.

Traded Fri, May 8. Filed Mon, May 11, 5:27 PM ET, after the close. Returns use the May 12 open and the Jun 25 close. Not investment advice.